Abstract
There are a large number of cardiovascular diseases that could be treated by myocardial gene transfer (1,2). These include congestive heart failure, ischemic heart disease, and cardiomyopathy. In addition to its potential for treatment of disease, myocardial gene transfer is useful for the analysis of gene expression and promoter function and for generating animal models of human disease such as pulmonary hypertension. The ideal vector for myocardial gene therapy should give efficient and stable transduction of cardiomyocytes in vivo. Recombinant adenovirus vectors have been used to transduce cardiomyocytes in rodents, rabbits, pigs, and humans by both intramyocardial injection and intracoronary infusion (3–5). Although efficient transduction can be obtained with adenovirus vectors, immune responses and elimination of transduced cells results in only transient expression in immunocompetent hosts. Vectors based on recombinant adeno-associated virus (rAAV) offer a number of attractive features and are emerging as promising gene transfer vehicles for many in vivo applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nabel, E. G. (1995) Gene therapy for cardiovascular disease. Circulation 91(2), 541–548.
Alexander, M. Y., Webster, K. A., McDonald, P. H., and Prentice, H. M. (1999). Gene transfer and models of gene therapy for the myocardium. Clin. Exp. Pharmacol. Physiol. 26(9), 661–668.
Guzman, R. J., Lemarchand, P., Crystal, R. G., Epstein, S. E., and Finkel, T. (1993) Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ. Res. 73(6), 1202–1207.
French, B. A., Mazur, W., Geske, R. S., and Bolli, R. (1994) Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 90(5), 2414–2424.
Barr, E., Carroll, J., Kalynych, A. M., Tripathy, S. K., Kozarsky, K., Wilson, J. M. and Leiden, J. M. (1994) Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene. Ther. 1(1), 51–58.
Svensson, E. C., Marshall, D. J., Woodard, K., Lin, H., Jiang, F., Chu, L., and Leiden, J. M. (1999) Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 99(2), 201–205.
Maeda, Y., Ikeda, U., Shimpo, M., Ueno, S., Ogasawara, Y., Urabe, M., et al. (1998) Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors. J. Mol. Cell Cardiol. 30(7), 1341–1348.
Su, H., Lu, R. and Kan, Y. W. (2000) Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc. Natl. Acad. Sci USA 97(25), 13801–13806.
Wright, M. J., Wightman, L. M., Lilley, C., de Alwis, M., Hart, S. L., Miller, A., et al. (2001) In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res. Cardiol. 96(3), 227–236.
Kaplitt, M. G., Xiao, X., Samulski, R. J., Li, J., Ojamaa, K., Klein, I. L., et al. (1996) Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann. Thorac. Surg. 62(6), 1669–1676.
Xiao, X., Li, J., and Samulski, R. J. (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72(3), 2224–2232.
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., et al. (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6(6), 973–985.
Clark, K. R., Liu, X., McGrath, J. P., and Johnson, P. R. (1999) Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10(6), 1031–1039.
Hauswirth, W. W., Lewin, A. S., Zolotukhin, S., and Muzyczka, N. (2000) Production and purification of recombinant adeno-associated virus. Methods Enzymol. 316, 743–761.
Wixson, S. K. and Smiler, K. L. (1997) Anesthesia and analgesia in rodents, in Anesthesia and Analgesia in Laboratory Animals (Kohn, D. F., Wixson, S. K., White, W. J., and Benson, G. J., eds.), Academic Press, New York, NY, pp. 174–175.
Lai, N. C., Roth, D. M., Gao, M. H., Fine, S., Head, B. P., Zhu, J., et al. (2000) Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation 102(19), 2396–2401.
Ito, B. R., Roth, D. M., Chenoweth, D. E., Lefer, A. M., and Engler, R. L. (1989) Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation. Circ. Res. 65(5), 1220–1232.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Chu, D., Thistlethwaite, P.A., Sullivan, C.C., Grifman, M.S., Weitzman, M.D. (2004). Gene Delivery to the Mammalian Heart Using AAV Vectors. In: Heiser, W.C. (eds) Gene Delivery to Mammalian Cells. Methods in Molecular Biology™, vol 246. Humana Press. https://doi.org/10.1385/1-59259-650-9:213
Download citation
DOI: https://doi.org/10.1385/1-59259-650-9:213
Publisher Name: Humana Press
Print ISBN: 978-1-58829-095-3
Online ISBN: 978-1-59259-650-8
eBook Packages: Springer Protocols